Tg Therapeutics (TGTX) Enterprise Value (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly Enterprise Value of -$75.1 million for Q1 2026, up 72.82% year-over-year from -$43.4 million in Q1 2025, and down 17.05% quarter-over-quarter from -$64.1 million in Q4 2025.
Tg Therapeutics (TGTX) Enterprise Value (2011 - 2026) Analysis & Trends
Tg Therapeutics' Enterprise Value history runs 16 years deep, the most recent figure standing at -$75.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 72.82% year-over-year to -$75.1 million; the TTM figure through Mar 2026 stood at -$75.1 million (up 72.82% YoY), while the FY2025 annual figure was -$64.1 million, up 51.21% from the prior year.
- Enterprise Value for Q1 2026 stood at -$75.1 million, down from -$64.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$64.1 million in Q4 2025, with the low at -$341.0 million in Q3 2024.
- The 5-year median for Enterprise Value is -$209.8 million (2024), against an average of -$194.1 million.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value plunged 50.16% in 2024, then jumped 72.82% in 2026.
- Tg Therapeutics' Enterprise Value stood at -$161.7 million in 2022, then plunged by 34.53% to -$217.5 million in 2023, then jumped by 39.55% to -$131.5 million in 2024, then soared by 51.21% to -$64.1 million in 2025, then slipped by 17.05% to -$75.1 million in 2026.
- Business Quant data shows TGTX's Enterprise Value at -$75.1 million in Q1 2026, -$64.1 million in Q4 2025, and -$235.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | -681.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -681.97 Mn |
| Mar 31, 2026 | -75.08 Mn |
| Dec 31, 2025 | -64.15 Mn |
| Sep 30, 2025 | -235.80 Mn |
| Jun 30, 2025 | -251.87 Mn |
| Mar 31, 2025 | -276.24 Mn |
| Dec 31, 2024 | -131.48 Mn |
| Sep 30, 2024 | -341.04 Mn |
| Jun 30, 2024 | -217.25 Mn |
| Mar 31, 2024 | -209.79 Mn |
| Dec 31, 2023 | -217.51 Mn |
| Sep 30, 2023 | -229.16 Mn |
| Jun 30, 2023 | -144.91 Mn |
| Mar 31, 2023 | -139.71 Mn |
| Dec 31, 2022 | -161.68 Mn |
| Sep 30, 2022 | -175.94 Mn |
| Jun 30, 2022 | -195.71 Mn |
| Mar 31, 2022 | -233.20 Mn |
| Dec 31, 2021 | -314.76 Mn |
| Sep 30, 2021 | -356.85 Mn |